Original Article
Robotic ureteral reimplantation for the management of ureterovaginal fistula: four cases at a single center
Translational Andrology and Urology
2021;
10
(10)
:3705-3713
.
(31 October 2021)
Histopathologic and clinical comparison of recurrent and non-recurrent urethral stricture disease treated by reconstructive surgery
Translational Andrology and Urology
2021;
10
(10)
:3714-3722
.
(31 October 2021)
A novel mHealth App (RyPros) for prostate cancer management: an accessibility and acceptability study
Translational Andrology and Urology
2021;
10
(10)
:3723-3736
.
(31 October 2021)
Should ureteroscopy be performed for patients after ureteral reconstruction with autologous onlay flap/graft?
Translational Andrology and Urology
2021;
10
(10)
:3737-3744
.
(31 October 2021)
A ureteral stricture disease score and classification system: correlation with upper urinary tract reconstructive surgery complexity
Translational Andrology and Urology
2021;
10
(10)
:3745-3755
.
(31 October 2021)
The impact of preoperative percutaneous nephrostomy as a treatment strategy before flexible ureteroscopy for impacted upper ureteral stones with hydronephrosis
Translational Andrology and Urology
2021;
10
(10)
:3756-3765
.
(31 October 2021)
Radiological features of renal pelvic hemangioma: a case series
Translational Andrology and Urology
2021;
10
(10)
:3766-3772
.
(31 October 2021)
ISPRF: a machine learning model to predict the immune subtype of kidney cancer samples by four genes
Translational Andrology and Urology
2021;
10
(10)
:3773-3786
.
(31 October 2021)
China county-based prostate specific antigen screening for prostate cancer and a cost-effective analysis
Translational Andrology and Urology
2021;
10
(10)
:3787-3799
.
(31 October 2021)
Quaking I-5 protein inhibits invasion and migration of kidney renal clear cell carcinoma via inhibiting epithelial-mesenchymal transition suppression through the regulation of microRNA 200c
Translational Andrology and Urology
2021;
10
(10)
:3800-3814
.
(31 October 2021)
Development of a highly sensitive digital PCR assay to quantify long non-coding RNA MYU in urine samples which exhibited great potential as an alternative diagnostic biomarker for prostate cancer
Translational Andrology and Urology
2021;
10
(10)
:3815-3825
.
(31 October 2021)
Effects of radical cystectomy, radiotherapy, and chemotherapy on the risk of long-term heart-specific death in bladder cancer patients
Translational Andrology and Urology
2021;
10
(10)
:3826-3836
.
(31 October 2021)
Overexpressing IFITM family genes predict poor prognosis in kidney renal clear cell carcinoma
Translational Andrology and Urology
2021;
10
(10)
:3837-3851
.
(31 October 2021)
Extreme body mass index is associated with poor survival outcomes after radical cystectomy: a retrospective cohort study in a Chinese population
Translational Andrology and Urology
2021;
10
(10)
:3852-3861
.
(31 October 2021)
Clinical effectiveness of microsurgical subinguinal varicocelectomy with enhanced recovery after surgery for varicocele
Translational Andrology and Urology
2021;
10
(10)
:3862-3872
.
(31 October 2021)
Review Article
Penile implant infection factors: a contemporary narrative review of literature
Translational Andrology and Urology
2021;
10
(10)
:3873-3884
.
(31 October 2021)
Case Report
Same problem, different approaches: transvesical and extravesical laparoscopic vesicovaginal fistula repair—case report
Translational Andrology and Urology
2021;
10
(10)
:3885-3890
.
(31 October 2021)
Management of tuberculous-contracted bladder with bilateral duplex collecting system: a case report with modified robotic urinary tract reconstructive surgery
Translational Andrology and Urology
2021;
10
(10)
:3891-3898
.
(31 October 2021)
Bladder mucosa-associated lymphoid tissue lymphoma progressed from chronic cystitis along with a comparative genetic analysis during long-term follow-up: a case report
Translational Andrology and Urology
2021;
10
(10)
:3899-3906
.
(31 October 2021)
Laparoscopic onlay lingual mucosal graft ureteroplasty combined with ureterovesical reimplantation for one-stage reconstruction of complex ureteral strictures: a case report
Translational Andrology and Urology
2021;
10
(10)
:3907-3914
.
(31 October 2021)
Editorial on Management of Advanced Genitourinary Malignancies1
Preface to “Management of advanced genitourinary malignancies”
Translational Andrology and Urology
2021;
10
(10)
:3915-3917
.
(31 October 2021)
Review Article on Management of Advanced Genitourinary Malignancies1
Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer—a narrative review
Translational Andrology and Urology
2021;
10
(10)
:3918-3930
.
(31 October 2021)
Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer—a narrative review
Translational Andrology and Urology
2021;
10
(10)
:3931-3945
.
(31 October 2021)
Original Article on Management of Advanced Genitourinary Malignancies1
KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patients
Translational Andrology and Urology
2021;
10
(10)
:3946-3952
.
(31 October 2021)
Review Article on Management of Advanced Genitourinary Malignancies1
Narrative review of challenges in the management of advanced neuroendocrine prostate cancer
Translational Andrology and Urology
2021;
10
(10)
:3953-3962
.
(31 October 2021)
Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer
Translational Andrology and Urology
2021;
10
(10)
:3963-3971
.
(31 October 2021)
Original Article on Management of Advanced Genitourinary Malignancies1
Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls
Translational Andrology and Urology
2021;
10
(10)
:3972-3985
.
(31 October 2021)
ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis
Translational Andrology and Urology
2021;
10
(10)
:3986-3999
.
(31 October 2021)
Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases
Translational Andrology and Urology
2021;
10
(10)
:4000-4008
.
(31 October 2021)
Editorial Commentary on Management of Advanced Genitourinary Malignancies1
A marrow-minded look at immune checkpoint blockade resistance in metastatic castration resistant prostate cancer
Translational Andrology and Urology
2021;
10
(10)
:4009-4013
.
(31 October 2021)
Review Article on Management of Advanced Genitourinary Malignancies1
Combination therapies involving checkpoint-inhibitors for treatment of urothelial carcinoma: a narrative review
Translational Andrology and Urology
2021;
10
(10)
:4014-4021
.
(31 October 2021)
Treatment options for advanced urothelial cancer after progression on chemotherapy and immune checkpoint inhibitors: a literature review
Translational Andrology and Urology
2021;
10
(10)
:4022-4035
.
(31 October 2021)
Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review
Translational Andrology and Urology
2021;
10
(10)
:4036-4050
.
(31 October 2021)
Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literature
Translational Andrology and Urology
2021;
10
(10)
:4051-4061
.
(31 October 2021)
Original Article on Management of Advanced Genitourinary Malignancies1
Assessment of prognosis by established prognosis scores and physicians’ judgement in mRCC patients: an analysis of the STAR-TOR registry
Translational Andrology and Urology
2021;
10
(10)
:4062-4074
.
(31 October 2021)
Review Article on Management of Advanced Genitourinary Malignancies1
Narrative review of developing new biomarkers for decision making in advanced testis cancer
Translational Andrology and Urology
2021;
10
(10)
:4075-4084
.
(31 October 2021)
Systemic treatment of penile squamous cell carcinoma—hurdles and hopes of preclinical models and clinical regimens: a narrative review
Translational Andrology and Urology
2021;
10
(10)
:4085-4098
.
(31 October 2021)
Erratum
Erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients
Translational Andrology and Urology
2021;
10
(10)
:4099
.
(31 October 2021)
Disclosure:
1. The series “Management of Advanced Genitourinary Malignancies” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Tilman Todenhöfer served as the unpaid Guest Editor for the series.
